Evidence map›Paper›PMID 26564054›Full record

ArticleGenome announcements2015

Draft Genome Sequence of a Metronidazole-Resistant Derivative of Gardnerella vaginalis Strain ATCC 14019.

Jessica A Schuyler, Eli Mordechai, Martin E Adelson, Scott E Gygax, David W Hilbert

Abstract read
In one paragraph

Article in Genome announcements, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Jessica A SchuylerFemeris Women's Health Research Center, Medical Diagnostic Laboratories, a member of Genesis Biotechnology Group, Hamilton, New Jersey, USA.
Eli MordechaiFemeris Women's Health Research Center, Medical Diagnostic Laboratories, a member of Genesis Biotechnology Group, Hamilton, New Jersey, USA.
Martin E AdelsonFemeris Women's Health Research Center, Medical Diagnostic Laboratories, a member of Genesis Biotechnology Group, Hamilton, New Jersey, USA.
Scott E GygaxFemeris Women's Health Research Center, Medical Diagnostic Laboratories, a member of Genesis Biotechnology Group, Hamilton, New Jersey, USA.
David W HilbertFemeris Women's Health Research Center, Medical Diagnostic Laboratories, a member of Genesis Biotechnology Group, Hamilton, New Jersey, USA dhilbert@mdlab.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We report the genome sequence of a metronidazole-resistant derivative of Gardnerella vaginalis ATCC 14019. This strain was obtained after serial selection to increase the MIC from 4 to ≥500 µg/ml. Two coding changes, in genes encoding a response regulator and an NAD(+) synthetase, arose during selection.

Identifiers

PMID26564054
PMCPMC4972788

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.